Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab.
Landi D, Grimaldi A, Bovis F, Ponzano M, Fantozzi R, Buttari F, Signoriello E, Lus G, Lucchini M, Mirabella M, Cellerino M, Inglese M, Cola G, Nicoletti CG, Mataluni G, Centonze D, Marfia GA.
Landi D, et al. Among authors: bovis f.
Neurol Neuroimmunol Neuroinflamm. 2022 Mar 10;9(3):e1157. doi: 10.1212/NXI.0000000000001157. Print 2022 May.
Neurol Neuroimmunol Neuroinflamm. 2022.
PMID: 35273036
Free PMC article.